Publication | Closed Access

Androgen dihydrotestosterone (DHT) promotes the bladder cancer nuclear AR-negative cell invasion via a newly identified membrane androgen receptor (mAR-SLC39A9)-mediated Gαi protein/MAPK/MMP9 intracellular signaling

Tumor BiologyUrologySignal TransductionAndrogen DihydrotestosteroneGenitourinary CancerMembrane Androgen ReceptorSignaling PathwayHormonal ReceptorCancer Cell BiologyProstatic DiseaseMedicineCell BiologyCell SignalingCancer ResearchEndocrine-related CancerGαi Protein/mapk/mmp9 Intracellular